Evolent Health, Inc. (EVH) Q2 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Welcome to the Evalent Earnings Conference Call for the second quarter ended June 30, 2026. As a reminder, this conference call is being recorded. Your hosts for the call today from Evalent are Seth Blackley, Chief Executive Officer, and Mario Ramos, Chief Financial Officer. This call will be archived and available later this evening and for the next week via the webcast on the company's website in the section titled Investor Relations. This conference call will contain forward-looking statements under U.S. federal laws. These statements are subject to risks and uncertainties that could cause actual results to differ materially from historical experience or present expectations. A description of some of the risks and uncertainties can be found in the company's reports that are filed with the Securities and Exchange Commission including cautionary statements included in our current and periodic filings. For additional information on the company's results and outlook, please refer to our second quarter press release issued earlier today. Finally, as a reminder, reconciliations of non-GAAP measures discussed during today's call to the most direct comparable GAAP measures are available in the summary presentation available in the investor relations section Thank you for joining us. and now I will turn the call over to Evelyn's CEO, Seth Blackley. Good morning and thank you for joining us. Today we reported a strong second quarter with results that reflect our continued ability to execute on our commitments. In a dynamic healthcare environment, our performance underscores the mission critical nature of our business, the dedication of our team and what we believe is the continued value of our solutions to our customers. For the quarter, Avalent reported total revenue of $6...